TY - JOUR
AU - Gallo, Marco
AU - Coutinho, Fiona J
AU - Vanner, Robert J
AU - Gayden, Tenzin
AU - Mack, Stephen C
AU - Murison, Alex
AU - Remke, Marc
AU - Li, Ren
AU - Takayama, Naoya
AU - Desai, Kinjal
AU - Lee, Lilian
AU - Lan, Xiaoyang
AU - Park, Nicole I
AU - Barsyte-Lovejoy, Dalia
AU - Smil, David
AU - Sturm, Dominik
AU - Kushida, Michelle M
AU - Head, Renee
AU - Cusimano, Michael D
AU - Bernstein, Mark
AU - Clarke, Ian D
AU - Dick, John E
AU - Pfister, Stefan
AU - Rich, Jeremy N
AU - Arrowsmith, Cheryl H
AU - Taylor, Michael D
AU - Jabado, Nada
AU - Bazett-Jones, David P
AU - Lupien, Mathieu
AU - Dirks, Peter B
TI - MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
JO - Cancer cell
VL - 28
IS - 6
SN - 1535-6108
CY - Cambridge, Mass.
PB - Cell Press
M1 - DKFZ-2017-02586
SP - 715 - 729
PY - 2015
AB - Mutations in the histone 3 variant H3.3 have been identified in one-third of pediatric glioblastomas (GBMs), but not in adult tumors. Here we show that H3.3 is a dynamic determinant of functional properties in adult GBM. H3.3 is repressed by mixed lineage leukemia 5 (MLL5) in self-renewing GBM cells. MLL5 is a global epigenetic repressor that orchestrates reorganization of chromatin structure by punctuating chromosomes with foci of compacted chromatin, favoring tumorigenic and self-renewing properties. Conversely, H3.3 antagonizes self-renewal and promotes differentiation. We exploited these epigenetic states to rationally identify two small molecules that effectively curb cancer stem cell properties in a preclinical model. Our work uncovers a role for MLL5 and H3.3 in maintaining self-renewal hierarchies in adult GBM.
KW - Antineoplastic Agents (NLM Chemicals)
KW - DNA-Binding Proteins (NLM Chemicals)
KW - Histones (NLM Chemicals)
KW - MLL5 protein, human (NLM Chemicals)
LB - PUB:(DE-HGF)16
C6 - pmid:26626085
DO - DOI:10.1016/j.ccell.2015.10.005
UR - https://inrepo02.dkfz.de/record/126558
ER -